Drive Wealth Management LLC decreased its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 3.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,553 shares of the conglomerate’s stock after selling 53 shares during the period. Drive Wealth Management LLC’s holdings in Danaher were worth $357,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America acquired a new position in Danaher during the 3rd quarter worth approximately $39,000. MidAtlantic Capital Management Inc. acquired a new position in Danaher during the 3rd quarter worth approximately $40,000. FSA Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth approximately $50,000. Finally, Darwin Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth approximately $55,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Stock Up 1.9 %
Shares of NYSE DHR opened at $250.51 on Tuesday. Danaher Co. has a 12-month low of $225.42 and a 12-month high of $281.70. The company has a market cap of $180.94 billion, a P/E ratio of 47.81, a P/E/G ratio of 4.43 and a beta of 0.83. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a fifty day moving average price of $235.33 and a 200 day moving average price of $253.62.
Danaher Announces Dividend
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on DHR shares. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research note on Thursday, October 31st. Citigroup decreased their price target on Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Royal Bank of Canada decreased their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. TD Cowen boosted their price target on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $285.55.
Read Our Latest Analysis on Danaher
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Manufacturing Stocks Investing
- Sizing Up a New Opportunity for NVIDIA Investors
- 3 Small Caps With Big Return Potential
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- How to Effectively Use the MarketBeat Ratings Screener
- The 3 Biggest M&A Stock Opportunities for 2025
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.